Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

The FDA has approved Lenacapavir a drug touted to be 999 effective in preventing HIV But it remains inaccessible for Indians ...

The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.

While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a newly approved jab could improve rates of protection.

Whereas the new HIV prevention drug, Lenacapavir, is a positive step towards HIV prevention, its cost is prohibitive. The ...

The FDA recently approved Gilead’s drug, lenacapavir, a powerful HIV prevention drug that only requires two shots a year. The O’Neill Institute for National and Global Health Law issued the ...

Gilead Sciences’ first quarter performance saw sales remain flat year over year, which did not meet Wall Street’s revenue ...

The 'sitting-rising test' is a non-aerobic fitness assessment of the muscle strength, flexibility, balance, and body composition of an individual ...

A recent study revealed that weed is linked with a doubled mortality risk from cardiac diseases. The study further discovered ...

India denies fake claims of US using its airspace for Iran strikes. PIB Fact Check confirms no Indian airspace was used in ...